Inactive Instrument
CannaVEST Corp Stock OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-15 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.04M 3.54M 3.29M 3.02M 5.69M 390M 5.78M 39.13M 15.31M 191M 15.16M 14.83M 659M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.76M 5.05M 4.69M 4.31M 8.11M 556M 8.24M 55.77M 21.82M 272M 21.61M 21.14M 939M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.05% | +0.91% | +52.59% | +151.71% | 1,048B | ||
| +2.00% | +0.70% | +55.53% | +50.20% | 603B | ||
| -1.09% | +3.48% | +37.03% | +76.22% | 452B | ||
| -0.42% | +1.65% | +30.05% | +21.05% | 327B | ||
| -0.16% | +2.39% | +36.91% | +37.33% | 283B | ||
| +1.68% | +2.73% | +24.14% | +17.94% | 259B | ||
| -1.40% | -0.06% | -22.24% | -42.39% | 219B | ||
| -0.05% | +3.04% | +23.72% | +55.89% | 198B | ||
| +0.05% | +0.23% | +20.37% | +61.63% | 162B | ||
| Average | -0.08% | +1.74% | +28.68% | +47.73% | 394.63B | |
| Weighted average by Cap. | -0.25% | +1.69% | +38.02% | +72.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.77M 12.79M 11.75M 22.12M 1.52B 22.47M 152M 59.52M 741M 58.94M 57.68M 2.56B | 13.79M 12.09M 11.23M 10.31M 19.42M 1.33B 19.73M 134M 52.26M 651M 51.75M 50.65M 2.25B |
| Net income | -2.39M -2.1M -1.95M -1.79M -3.37M -231M -3.43M -23.19M -9.07M -113M -8.99M -8.79M -390M | -958K -840K -780K -717K -1.35M -92.5M -1.37M -9.28M -3.63M -45.21M -3.6M -3.52M -156M |
| Net Debt | 325K 285K 265K 243K 458K 31.38M 465K 3.15M 1.23M 15.34M 1.22M 1.19M 53M | 1.72M 1.51M 1.4M 1.29M 2.42M 166M 2.46M 16.64M 6.51M 81.07M 6.45M 6.31M 280M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions

















